Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05206500 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

NextGen - Clinical Implication of Next Generation Sequencing

StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Notable Primary and study completion dates: Dec 2026 to Dec 2028
    • Site contact updated
    v10
  2. Notable Primary completion date: Dec 2025 to Dec 2026
    • Study completion date: Jun 2026 to Dec 2026
    v9
  3. Minor Eligibility criteria revisedv8
  4. Notable Primary completion date: Dec 31, 2024 to Dec 2025
    • Study completion date: Jun 1, 2025 to Jun 2026
    v7
  5. Minor Re-verified, no change to tracked fieldsv6
Show 4 earlier versionsHide 4 earlier versions
  1. Notable Primary completion date: Dec 2022 to Dec 31, 2024
    • Study completion date: Dec 2022 to Jun 1, 2025
    v5
  2. Notable Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of May 2022 to May 17, 2022
    • Site details revised
    v4
  3. Minor Start date: Apr 2022 to May 2022v3
  4. Minor Start date: Mar 2022 to Apr 2022v2
  1. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Recently more advanced techniques, including Polymerase Chain Reaction (PCR) and Next Generation Sequencing (NGS) are available to detect bacteria in urine based on bacterial genomes. Comparing to traditional culture, these techniques have more sensitivity and could potentially be of a great help in patients with Colony Count of less than 10,000 and more than zero.
Trial Details
NCT Number NCT05206500
Lead Sponsor Wake Forest University Health Sciences
Conditions
(from sponsor)
Urinary Tract Infections
Related terms Urinary Tract Infections
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov